CCL2 chemokine inhibition primes the tumor vasculature for improved nanomedicine delivery and efficacy
Diana Möckel, Matthias Bartneck, Patricia M. Niemietz, Maike Wagner, Josef Ehling, Elena Rama, Marek Weiler, Felix Gremse, Dirk Eulberg, Robert Pola, Michal Pechar, Tomáš Etrych, Gert Storm, Fabian Kießling, Frank Tacke, Twan Lammers
Topics & Concepts
Drug deliveryCancer researchNanocarriersCCR2Tumor microenvironmentNeovascularizationPharmacologyChemokineMedicineAngiogenesisChemistryImmunologyDrugChemokine receptorInflammationTumor cellsOrganic chemistryImmune cells in cancerChemokine receptors and signalingAngiogenesis and VEGF in Cancer